18hon MSN
Researchers demonstrate breakthroughs in cancer treatment quality through AI-enhanced data analytics
Cancer researchers at the University of Tennessee Health Science Center have published three new studies demonstrating how ...
Discusses Oncology Pipeline Advances and Phase III Clinical Updates at Science and Technology Day December 15, ...
The Virginia Aquarium announces a new aquatic veterinary internship starting in 2026, offering clinical training for graduate ...
Europe’s share of global clinical trials has slid from over 25% to 19.3% in the past decade, according to the European ...
TipRanks on MSN
Tiziana Life Sciences rings Nasdaq closing bell celebrating milestone in biotechnology
Tiziana Life Sciences ( ($TLSA) ) has shared an update. On December 17, 2025, Tiziana Life Sciences celebrated its advancements in biotechnology ...
Immense progress in gene-editing, drug discovery and conservation are just some of the reasons to be cheerful about 2025.
First Patient Dosed with Intranasal Foralumab in Randomized, Placebo-Controlled Phase 2 TrialBuilds on Recent Evidence of Persistent Neuroinflammation in Alzheimer's Patients Treated with Anti-Amyloid ...
Your skeleton is 20 pounds of miracle, contributing to your mood, memory, and metabolism. Learn why better mental health may, ...
Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine ...
UTHealth Houston, in collaboration with The University of Texas Medical Branch at Galveston (UTMB Health), has been awarded ...
The clinical trial industry is at a critical juncture where traditional methods are proving insufficient for managing today’s ...
First Patient Dosed with Intranasal Foralumab in Randomized, Placebo-Controlled Phase 2 TrialBuilds on Recent Evidence of Persistent Neuroinflammation in Alzheimer’s Patients Treated with Anti-Amyloid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results